Ranking · Spring 2026 · Healthcare · Therapeutics

FinalDose

Programmable DNA drug destroying all cancers, unlocking 80% of targets

3.3%

odds of being acquired in the next two years

0.5× the average (6.8%)

#4296 of 4,339 active YC companies · top 100%

Team of 5 · Oxford, England, United Kingdom

Raises the odds

↑ team of 3–5

Lowers the odds

↓ under 1.5 years since YC

↓ industry: Healthcare

↓ new to the directory in the last six months

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads FinalDose's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

finaldose.ai YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub